Heterogeneity of ductal carcinoma in situ and its effects on management.
about
Predicting invasive breast cancer versus DCIS in different age groupsCOX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentHeterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the BreastEffect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.International variation in management of screen-detected ductal carcinoma in situ of the breast.Designing vaccines to prevent breast cancer recurrence or invasive disease.Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast.In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.Role of the radiotherapy boost on local control in ductal carcinoma in situThe effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomesRole of RNA binding protein HuR in ductal carcinoma in situ of the breastA Molecular Portrait of High-Grade Ductal Carcinoma In Situ.Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialN-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma.Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans.State of the evidence: the connection between breast cancer and the environment.Endocrine Therapy Initiation and Medical Oncologist Utilization Among Women Diagnosed with Ductal Carcinoma in Situ.Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study.Epidemiology of ductal carcinoma in situ in Western Australia: implications for surgical margins and management.The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy
P2860
Q21261250-0FCDCB21-30C3-410E-A81F-008241B2C02EQ33877411-028443FE-C755-42A1-A269-816CB9B77934Q34207931-6BCCDE9D-CB4B-4D92-9E5C-1F7E676826BDQ34478845-CE7EBA64-A570-4236-BAC1-AB823DF59AE7Q34764889-2FB0FCE5-1F6F-4828-B414-B1AAAE1EDFC3Q35546337-69D85EAD-11DC-4391-84A3-50E33A115AFBQ35596095-4399724F-B5AE-43D1-AB1B-440B5AA014D9Q35882253-F3DA1902-6916-4020-BF0B-39CFB105C47BQ35896750-AB37530E-6973-48E7-B153-39A14C35298AQ35904098-6EF62FFA-B3CD-4C6F-9C17-F1748149F484Q35949533-7C64DD7C-0532-4762-AF97-5A9170238399Q36117541-6F2B0C0C-7D6A-4565-8779-72BACCFF8911Q36418983-043FD218-9BCA-412B-BEA7-50045169864DQ36622366-A877C9C6-271C-483F-B4BF-BB0A70A8C9ECQ36625021-066A1ABB-0002-4C4D-97D3-22F5660ADEA8Q37111115-76A9FE4C-3970-4E65-AD71-2D092268792BQ37160710-5614FDD5-3B39-49E9-8B23-8557A096DCA2Q37363605-101F1A3D-6FDE-4D7C-865B-EAEFBF07015EQ37408121-B536DF10-6A7C-452F-818C-6CF474C2D3CAQ38837580-52701C98-0E33-4837-98B4-81F0F6AE664EQ43241806-66B18261-F761-4C8A-9310-760275A2C683Q50692924-41D4E5D1-8AD6-4BDB-83C6-3CB458E1C823Q57580742-A0FDF15B-E652-4247-9E0F-6ECBB4881EB2
P2860
Heterogeneity of ductal carcinoma in situ and its effects on management.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Heterogeneity of ductal carcinoma in situ and its effects on management.
@ast
Heterogeneity of ductal carcinoma in situ and its effects on management.
@en
type
label
Heterogeneity of ductal carcinoma in situ and its effects on management.
@ast
Heterogeneity of ductal carcinoma in situ and its effects on management.
@en
prefLabel
Heterogeneity of ductal carcinoma in situ and its effects on management.
@ast
Heterogeneity of ductal carcinoma in situ and its effects on management.
@en
P1433
P1476
Heterogeneity of ductal carcinoma in situ and its effects on management.
@en
P2093
Bruno Cutuli
Kefah Mokbel
P304
P356
10.1016/S1470-2045(06)70861-0
P577
2006-09-01T00:00:00Z